U.S. Software Stock News

Sunoco (SUN) is in focus after its recent share performance, with the stock closing at $66.50 and showing mixed returns over the past week, month, and past 3 months that invite closer attention. See our latest analysis for Sunoco. The recent 2.75% 1 day share price return adds to Sunoco’s positive trend, with a 26.11% year to date share price return and a 5 year total shareholder return of 147.78% pointing to momentum that long term holders will be watching closely. If Sunoco’s move has you...

Recently, analysts at Freedom Broker upgraded The Mosaic Company following an improvement in sulfur supply tied to a US–Iran agreement, while other brokers highlighted rising input costs across the fertilizer industry that are affecting producers’ margins. The focus on sulfur availability is important because sulfur is a critical input for phosphate fertilizer production, meaning supply improvements can materially influence Mosaic’s cost base and profitability prospects. We’ll now examine...

How NVIDIA Stock Has Been Performing Recently NVIDIA (NVDA) has drawn fresh attention after recent trading, with the stock down 1.6% over the past day and 8.6% over the past week. Shares also declined about 9% over the past month. Despite this pullback, NVIDIA shows a gain of roughly 16.6% over the past 3 months and a total return of about 22.2% over the past year. Year to date, the stock is up close to 1.9%, with a market value around US$4.66t based on the latest close of US$192.53. See our...

Nuvation Bio (NUVB) recently completed a $250 million offering of 0.75% convertible senior notes due 2032, drawing investor attention as the company refines its capital structure and funds its oncology development pipeline. See our latest analysis for Nuvation Bio. Nuvation Bio’s share price has risen 39.51% over the past 90 days and 18.20% over the past 30 days, while its 1 year total shareholder return of 192.75% contrasts with a year to date share price decline of 34.15%. This suggests...

ATI (ATI) has drawn attention after recent trading, with the stock closing at US$197.40 and showing mixed short term moves, including a decline over the past week and gains over the past month. See our latest analysis for ATI. Zooming out, ATI’s recent pullback sits within a strong run, with a 30 day share price return of 12.7% and a year to date share price return of 65.6%. The 1 year total shareholder return of 127.42% points to momentum that has so far been rewarded by the market. If ATI’s...

Nuclear energy stocks sit at the crossroads of two powerful forces right now: steady demand for reliable baseload power and growing interest in lower carbon energy sources. With global data pointing to resilient consumption, ongoing fiscal support in major economies, and persistent focus on energy security, many investors are looking for ways to add exposure to this theme in a more targeted way. This Nuclear Energy Stocks screener filters companies across uranium production, enrichment, and...

Getty Realty Stock Overview After Recent Performance Shift Getty Realty (GTY) has drawn fresh attention after a period of positive share performance, with the stock up over the past month and past 3 months, prompting investors to revisit its fundamentals and income profile. See our latest analysis for Getty Realty. Beyond the recent monthly gains, Getty Realty’s share price return of 23.37% year to date and 31.26% total shareholder return over one year point to building momentum as investors...

Earlier this week, ASA Gold and Precious Metals Limited appointed board member Paul Kazarian as President and Principal Executive Officer and shifted to internal management while its Special Committee evaluates potential external management arrangements. By creating a board-level Investment Committee led by Kazarian and ending the officer roles of Axel Merk and Peter Maletis, ASA signaled a clear change in how its portfolio and governance will be overseen during this review period. We will...

Ferrari (NYSE:RACE) has replaced its long-serving marketing chief following strong backlash to its first electric vehicle, the Luce. The shake-up comes soon after the Luce launch, as criticism of the model’s positioning and design triggered internal review. The change signals management focus on how Ferrari presents its EV plans to customers and investors. Ferrari, best known for its high performance sports cars and racing heritage, is under closer scrutiny as the auto industry pushes...

Affordable treats are drawing steady foot traffic even as broader US consumer confidence stays weak. That mix of resilient demand and rising input costs is creating a very specific test for confectionery and snack food stocks. With specialty candies, imported sweets, and neighborhood shops all facing higher tariffs, shipping expenses, and supply risks, some companies may be better positioned than others to handle pricing and product availability. This article looks at three stocks exposed to...

Palomar Holdings (PLMR) drew investor attention after reporting Q1 revenue growth of 59.7% year on year and a 5.8% beat versus analyst expectations, with shares rising about 5% to around $116.30. See our latest analysis for Palomar Holdings. The recent Q1 beat comes on top of a 7.2% 1 day share price return and a 13.1% 7 day share price return, although Palomar Holdings’ 1 year total shareholder return is down 17.6% after a very large 3 year total shareholder return of about 7x. If strong...

Quanta Services (PWR) is in focus after Hyosung HICO agreed to form HYOSUNG HICO BREAKER, LLC, a joint venture that will manufacture high-voltage gas circuit breakers at Quanta's Canonsburg, Pennsylvania, facility. See our latest analysis for Quanta Services. Quanta Services’ recent joint venture news comes after a strong run, with the share price down 4.3% on the day to $687.87 but still showing a 90 day share price return of 28.9% and a 1 year total shareholder return of 80.6%. This...

Recycling earnings and dividend track record move into focus Eastman Chemical (EMN) is drawing fresh attention after its Kingsport methanolysis facility contributed an additional $60 million in earnings in 2025, with another $30 million targeted for 2026, while the company extends a 16-year streak of dividend increases. See our latest analysis for Eastman Chemical. At a share price of $70.71, Eastman Chemical has a year to date share price return of 9.9%, while its 1 month share price return...

In late June 2026, GE Vernova Inc. (NYSE:GEV) was added to the Russell Top 50 Index, following earlier disclosure that it secured about US$2.40 billion in data center equipment orders in the first quarter of 2026 amid rising electrification and grid-modernization demand. This combination of index inclusion and large AI-related power infrastructure orders highlights how GE Vernova is becoming a central supplier to the electricity demands behind data center growth. We will now examine how GE...

Earlier this month, Wix.com Ltd. announced a collaboration with Microsoft Corporation to integrate its Wix Harmony website creation tools directly into Microsoft 365 Copilot, allowing users to generate and manage feature-rich Wix sites via natural-language prompts inside the Microsoft 365 interface. This move effectively embeds Wix's broader ecosystem, covering commerce, scheduling, payments, analytics, and more, into everyday productivity workflows, potentially deepening its reach among...

In recent months, Altria Group has responded to pressure on its traditional cigarette business and tighter regulation by accelerating investment in smoke-free alternatives, particularly oral nicotine pouches, while still maintaining its dividend and share repurchase program. This combination of funding reduced-risk products with cash flows from legacy brands, alongside continued capital returns, highlights how Altria is trying to realign its business model without disrupting shareholder...

With the U.K. economy slipping 0.1% in April 2026 and war driven energy costs squeezing both households and businesses, many investors are rethinking how much risk sits in their portfolios. Defensive Consumer Staples Stocks can sometimes offer a steadier ride when growth cools and rate cuts look distant, but not all stocks respond to the same news in the same way. This article looks at three stocks from a Defensive Consumer Staples Stocks screener that appear positively exposed to the latest...

Fluor stock: new healthcare infrastructure mandate from Voyageur Fluor (FLR) stock is in focus after Voyageur Pharmaceuticals engaged the company to run feasibility studies for two radiology contrast drug projects tied to Bayer backed iodine and barium manufacturing plans. See our latest analysis for Fluor. Fluor's latest healthcare infrastructure mandate comes after a strong run, with a 30 day share price return of 17.22% and a 5 year total shareholder return of 208.63%, suggesting momentum...

IBM (NYSE:IBM) has introduced a sub-1 nanometer "nanostack" chip architecture, described as offering up to 50% more performance or 70% greater energy efficiency compared with current 2 nm chips. The company also launched Anderon, a standalone quantum wafer foundry in the U.S. focused on manufacturing quantum chips at commercial scale. Together, these moves target future AI, data center hardware, and quantum computing demand, and expand IBM's role in semiconductor and quantum...

Comfort Systems USA (FIX) is back in focus after investors digested fresh analyst commentary on its growing project backlog, stronger free cash flow margins, and supportive earnings estimate revisions, alongside recent leadership changes. See our latest analysis for Comfort Systems USA. Despite a sharp 8.1% decline in the 1 day share price return and a softer 7 day share price return, Comfort Systems USA still shows strong momentum, with a 90 day share price return of 45.6% and a very large 5...

UiPath (PATH) is back in focus after mixed Q1 results, where revenue outperformance contrasted with weaker full year billings guidance compared with other automation software stocks, even as new products like Maestro Case gather customer interest. See our latest analysis for UiPath. The share price reaction around UiPath's Q1 release and Maestro Case updates has been choppy. A 6.04% 1 day share price return and 2.53% 7 day share price return sit against a 30 day share price return that is...

Eli Lilly and Company recently received a positive opinion from the European Medicines Agency’s human medicines committee for Jaypirca (pirtobrutinib) to treat adults with chronic lymphocytic leukemia across all lines of therapy, while U.S. Medicare approved a new GLP-1 Bridge program that will give eligible patients access to Zepbound and Foundayo weight-management drugs for a US$50 monthly copay. Together, these developments highlight how Lilly is extending its reach in both oncology and...

Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA approval for Tryngolza (olezarsen) as the first treatment to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia. The company plans a U.S. commercial launch of Tryngolza next month, targeting high risk patients with limited existing options. Ionis also signed a licensing agreement granting Recordati exclusive rights to develop and commercialize zilganersen for Alexander disease outside the U.S.,...

Recently, analyst commentary from Truist pointed to a credible path for Covista’s Chamberlain University to return to mid-to-high single-digit enrollment growth, reinforcing management’s focus on expanding this healthcare education segment. The emphasis on Chamberlain’s potential enrollment recovery highlights how improving student intake at a single, core institution could meaningfully influence Covista’s overall education portfolio and earnings mix. We’ll now examine how this renewed...